A novel CD20/CD3 T cell engager designed from Rituximab targeting CD20+cancer with multiple mechanisms.

Cai, W; Dong, J; Kankanamalage, SG; Titong, A; Shi, J; Jia, Z; Wang, B; Huang, C; Zhang, J; Lin, J; Kan, SZ; Zhou, J; Liu, Y

CANCER RESEARCH, 2021; 81 (13):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索